Sildenafil is a treatment option for PAH patients that is found to offer an additional 1-3 life years gained for PAH patients compared to beraprost, currently the only treatment available in the benefit package under the National Social Health Insurance (Jaminan Kasehatan Nasional – JKN) of Indonesi

Due to the increasing burden of non-communicable diseases (NCDs) in aging populations and the prevalence of unhealthy lifestyles, end-stage renal disease (ESRD) that results from NCDs is a growing concern in Indonesia. With the target of achieving Universal Health Coverage (UHC) by 2019, public prov

Since 2013, HITAP has supported HTA development and capacity building in the Philippines. In 2019, the Philippines mandated the provision of universal health coverage to all Filipinos. To support the decision-making for this promising undertaking, the partners continue their collaboration through technical assisatance on national HTA guidelines, on

Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi

HITAP is working with partners to support the Kenyan Ministry of Health to institutionalise health priority setting at the national level of the health system. A relationship between the Kenyan Mininstry of Health and the Thai Ministry of Public Health has been formalised through a memorandum of understanding (MoU). The collaboration focuses on hel

To execute planned activities and to seize opportunities to support partners in India build capacity in HTA and in implementation of UHC. HITAP will use the remaining funds to support a Post-Doctoral Fellow from PGIMER. Further, depending on the demand, HITAP may support its academic partners, CMC Vellore and JIPMER, the latter being a HTA Resource

HITAP collaborated with the Ethiopia Institute of Public Health (EPHI) to support the use of evidence in the country for COVID-19 and beyond. Areas of collaboration include technical and capacity-building support for a systematic review of economic evaluations of pandemic interventions. In 2020, HITAP provided an online training on the conduct of a

Bhutan\'s Ministry of Health, especially the Essential Medicine and Technology Division (EMTD), is one of HITAP\'s long-term partners. From 2018 to 2019, HITAP with PATH supported Bhutan to conduct an economic evaluation for the implementation of a national program for rotavirus vaccination. HITAP also provided and continues to find opportunities f

Full text: http://link.springer.com/article/10.1007s40273-015-0360-1